Melanoma
Rare Diseases Report 2021
Metastatic uveal melanoma: New drugs in pipeline, but prognoses remain grim
As many as 50% of patients with this form of eye cancer develop tumors elsewhere.
Latest News
FDA expands pembrolizumab approval for advanced melanoma
Approval was based on first interim findings from the randomized, placebo-controlled KEYNOTE-716 trial, which evaluated patients with stage IIB...
From the Journals
‘Highest survival’ with combo immunotherapy in advanced melanoma
The results represent the longest median overall survival seen in a phase 3 trial of advanced melanoma.
From the Journals
Differences in response to immunotherapy in men versus women
It remains unclear whether the increased risk for death in women is a result of treatment side effects or lack of efficacy.
Opinion
Improving statewide reporting of melanoma cases
Dermatology is unique in that our pathology specimens are not routinely passed through a hospital pathology laboratory.
From the Journals
AI: Skin of color underrepresented in datasets used to identify skin cancer
“There was massive underrepresentation of skin lesion images from darker-skinned populations,” the authors wrote.
From the Journals
Dogs show potential as medical detectives in breast cancer
First preliminary study indicating the feasibility of developing a new breast cancer screening method using urine samples based on volatile...
From the Journals
Skin checks reduce all-cause but not melanoma-specific deaths
Routine skin checks, a surrogate for skin-cancer screening, did not outperform patient self-examination at detecting lesions.
From the Journals
In and out surgeries become the norm during pandemic
The number of same-day discharges has grown for various surgeries but it’s not always the right or the preferred choice, experts say.
From the Journals
Antibiotic and glucocorticoid use before cancer therapy could have detrimental effect on outcomes
Observational study finds that antibiotics and glucocorticoids at 10 mg daily when given within 1 month before or after immune checkpoint...
Conference Coverage
Fecal microbiota transplants may improve resistance to melanoma immunotherapy
“The big question that’s lacking is why and how does FMT work, and how can we make the response better?”